FDA announces that the Quinapril blood pressure medicine recalls for contaminants that may cause cancer.
The Quinapril Blood Pressure Tablets
According to the Food and Drug Administration(FDA), the Quinapril tablets prescribed to lower blood pressure medication were voluntarily recalled last week by drug manufacturer Lupin Pharmaceuticals Inc. over concerns that the pills could increase the risk of cancer.
Lupin Pharmaceuticals Inc.’s Quinapril tablets are made as 20 mg and 40 mg and may contain an elevated level of nitrosamine impurity, N-Nitroso-Quinapril, above the acceptable daily intake level. Nitrosamine impurities are common in consumables, including cured and grilled meats, vegetables, and dairy products, according to the FDA.
Patients who are on the medication don’t need to stop taking it immediately but are advised to discuss alternative treatment with their healthcare provider. The implicated lots have expiration dates range from December 2022 to March 2024 and were dispered from March 2021 to Sept. 2022. The bottles had a 90-count capacity, additionally this is affected lot numbers here.
Lupin Pharmaceuticals Inc. Statements
Lupin Pharmaceuticals Inc. said that they already halted the production of the drug in September and was working with distributors to arrange for the return of the recalled product medicine. No illnesses linked with the recalled medicine have been reported so far, the company said.